Nature Medicine has published a peer-reviewed paper detailing the experimental glioblastoma cancer treatment developed by Professor Georgina Long AO, Medical Director of Melanoma Institute Australia, paving the way for a clinical trial to be conducted by researchers at The Brain Cancer Centre in Melbourne.
A heartfelt thank you to our incredible community of fundraisers. Your passion, dedication, and endless creativity never cease to inspire us. We are so grateful for your support!
Skin checks are an important tool in the early detection of skin cancers. MIA & others in the skin cancer community have advocated for a more systematic, targeted & equitable approach to skin cancer screening in Australia. As a result, the Australian Gov't has allocated $10m for development of a Roadmap for a National Targeted Skin Cancer Screening Program.
Newly released long-term data from a groundbreaking clinical trial for advanced melanoma patients whose disease had spread to their brain has proven that long-term disease control has been achieved for over 50% of patients given combination immunotherapy as first line treatment.
Prof Richard Scolyer AO has announced that he has decided to step down from his role as Co-Medical Director of Melanoma Institute Australia. Richard has been in this role since January 2017.
Alina Mueller is a clinician scientist at the Department of Dermatology at the University Hospital Basel, Switzerland, specialising in Dermato-Oncology. Read about her four-week Medical Oncology observership at MIA!
Marie Brinch-Møller Weitemeyer has recently completed a four-week surgical observership at Melanoma Institute Australia as part of her PhD program. Learn about her experience!
